FDA ex­tends re­search agree­ment with MIT-li­censed or­gan-on-chip sys­tems

The FDA on Wednes­day ex­tend­ed its four-year agree­ment with CN Bio, a de­vel­op­er of sin­gle- and mul­ti-or­gan-on-chip sys­tems used for drug dis­cov­ery, for an­oth­er three years.

CN Bio said the scope of the re­search per­formed by the FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search has ex­pand­ed to in­clude the ex­plo­ration of the com­pa­ny’s lung-on-a-chip sys­tem to help with the agency’s eval­u­a­tion of in­haled drugs, in ad­di­tion to the agency’s work on its liv­er mod­el.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.